5.21
Ipertensione portale
L’ipertensione portale è un aumento della pressione ematica all’interno del sistema venoso portale. In condizioni normali, questa pressione è inferior…
L'ipertensione portale è definita come un aumento della pressione venosa portale superiore a 5 millimetri di mercurio.
Quando supera i 10-12 mmHg, la condizione diventa clinicamente significativa e inizia a disturbare la circolazione normale.
La causa più comune è la cirrosi, in cui le cicatrici fibrotiche all'interno del fegato ostacolano il flusso sanguigno.
Altre cause possono essere classificate come preepatiche, come trombosi della vena porta, intraepatica, come la schistosomiasi, e postepatica, come l'insufficienza cardiaca destra.
Con l'aumento della resistenza epatica, il sangue proveniente dal tratto gastrointestinale viene deviato attraverso vasi collaterali che bypassano il fegato. Questi percorsi collaterali—come quelli dell'esofago—aiutano a ridurre la pressione portale ma permettono anche al sangue di bypassare il metabolismo epatico.
Questa riduzione del processamento causa l'accumulo di tossine, come l'ammoniaca, nel sangue e raggiunge il cervello, portando all'encefalopatia epatica.
Nel frattempo, l'aumento della pressione provoca congestione venosa negli organi vicini. Le varici possono formarsi in aree vulnerabili come l'esofago e lo stomaco. Queste varici possono rompersi, causando un sanguinamento grave.
View the full transcript and gain access to JoVE Core videos
Q1: What pressure level defines clinically significant portal hypertension?
Portal hypertension becomes clinically significant when portal venous pressure exceeds 10 to 12 millimeters of mercury, compared to the normal level below 5 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge, disrupting normal circulation and triggering pathophysiological changes throughout the body.
Q2: Why does cirrhosis cause portal hypertension?
Cirrhosis causes portal hypertension through fibrotic scarring within the liver that obstructs blood flow. This fibrosis narrows or obstructs the intrahepatic vasculature, increasing resistance to portal blood flow. As resistance rises, blood from the gastrointestinal tract cannot pass through the portal system efficiently, leading to increased pressure.
Q3: What are prehepatic and posthepatic causes of portal hypertension?
Prehepatic causes, such as portal vein thrombosis, obstruct blood flow before it reaches the liver. Posthepatic causes, like right-sided heart failure, impede blood outflow from the liver by elevating central venous pressure, which is transmitted backward into the hepatic circulation, increasing upstream pressure.
Q4: How do portosystemic collaterals develop and what are their consequences?
When liver resistance increases, blood is rerouted through portosystemic collaterals—alternative vessels that bypass the liver. While these collaterals relieve pressure, they allow blood to bypass hepatic metabolism, causing toxins like ammonia to accumulate in systemic circulation and reach the brain, potentially leading to hepatic encephalopathy.
Q5: Where do esophageal varices form and why are they dangerous?
Esophageal varices are dilated veins that form in the esophagus and stomach due to rising portal pressure causing venous congestion in nearby organs. These fragile varices are prone to rupture, posing a significant risk of life-threatening gastrointestinal bleeding when damaged or stressed.
Q6: What pulmonary complications can result from portal hypertension?
Portal hypertension can cause hepatopulmonary syndrome, characterized by intrapulmonary vascular dilation and impaired oxygenation, and portopulmonary hypertension, marked by elevated pulmonary arterial pressure from altered vascular tone. These complications demonstrate how portal hypertension extends beyond the liver, affecting multiple organ systems.
Q7: How does schistosomiasis contribute to portal hypertension?
Schistosomiasis is a parasitic infection that affects the hepatic portal system and often leads to periportal fibrosis. This fibrotic scarring impedes blood flow through the liver, increasing resistance and elevating portal venous pressure, similar to the mechanisms seen in cirrhosis-related disease.